Dr. Nitasha Kumar, MD

Dr. Kumar practices at Arthritis and Rheumatism Associates - Rockville 5 in Rockville, Maryland.

Dr. Kumar's NPI, 1093135113, was assigned on April 16, 2014. Dr. Kumar holds Maryland license D0088199.

Dr. Kumar's primary practice is Arthritis and Rheumatism Associates - Rockville 5, at 14995 Shady Grove Rd Suite 500, Rockville, MD 20850. The practice phone is (301) 942-3126.

Dr. Kumar's primary practice is Arthritis and Rheumatism Associates - Rockville 5 in Rockville, Maryland. The medical group on file is Arthritis and Rheumatism Associates, P.C. Dr. Kumar's employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kumar practices. Vendor and product names are available with a free account.

Rheumatology is Dr. Kumar's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dmand AI has Dr. Kumar's licenses on file in 2 states: Maryland and New Jersey.

CMS data shows 113,920 Medicare services from Dr. Kumar across 57 procedure codes in 2024, for 1,557 Medicare patients. Medicare paid $1,556,178 for them. Every service was in an office.

CMS counts 1,557 Medicare patients who saw Dr. Kumar in 2024. The largest group is 75 to 84, with 639 patients. 75% of them have high cholesterol, and 72% have osteoporosis. 7% are also on Medicaid. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kumar's median patient age at 70, with 83% women.

In 2024, Dr. Kumar wrote 2,105 Medicare Part D claims for 387 patients. 92% of them were for generic drugs. CMS names the drug for 1,900 of them, across 38 drugs with 11 or more claims each, at $1,051,881 in total drug cost. In 2023, CMS named 1,524 claims across 31 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Kumar for performance year 2024, reported as part of a group. Dr. Kumar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kumar as offering telehealth.

Dmand AI links 15 papers to Dr. Kumar, published from 2011 to 2024. 2018 was the busiest year, with 2. The most frequent topics are Virus Latency, CD4-Positive T-Lymphocytes and HIV-1. Dr. Kumar has published most often in J Immunol. Dr. Kumar's most frequent co-authors are Joseph K. Wong, MD, Steven Yukl, MD and Ann Md Chahroudi, MD, PhD.

CMS Open Payments shows 22 general payments to Dr. Kumar from 8 drug and device companies from 2018 to 2025. Honoraria make up the largest share, 48% of the total. Horizon Pharma plc paid the most, $1,000.